MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-10-2023
Country |
 USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
104 M |
Market Cap[1] |
$ 4.46 B |
EBITDA (LTM) |
$ 391 M |
P/E (LTM) |
- |
P/S (LTM) |
0.84 |
EPS (LTM) |
0.91 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 118.08 | -1.39 % | $ 35.9 B | NYSE,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 21.96 | 6.81 % | $ 236 M | Nasdaq Global Market |  China |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 22.44 | 27.69 % | $ 1.2 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Co-Diagnostics
CODX
|
$ 1.48 | 4.23 % | $ 1.97 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.61 | -0.04 % | $ 684 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 177.57 | -1.71 % | $ 8.8 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 515.07 | -0.67 % | $ 14.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 193.3 | -2.43 % | $ 138 B | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 2.2 | - | $ 9.73 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 131.91 | -0.27 % | $ 21 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.14 | -6.28 % | $ 1.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.28 | -1.54 % | $ 2.01 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.19 | 0.12 % | $ 490 M | Nasdaq Global Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 28.68 | -1.34 % | $ 20 B | NYSE |  Niderland |
 |
Guardant Health
GH
|
$ 85.43 | 0.67 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Anixa Biosciences
ANIX
|
$ 2.85 | -2.73 % | $ 92.5 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.2 | 4.27 % | $ 5.05 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 115.41 | -0.94 % | $ 9.52 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 267.26 | 0.13 % | $ 22.2 B | NYSE,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 6.78 | -1.81 % | $ 283 M | NYSE American | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Soleno Therapeutics
SLNO
|
$ 52.56 | -0.03 % | $ 2.67 B | Nasdaq Capital Market | USA |
 |
Celcuity
CELC
|
$ 125.57 | 1.7 % | $ 5.87 B | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 5.0 | -3.76 % | $ 463 M | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 83.98 | 0.05 % | $ 5.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Neuronetics
STIM
|
$ 1.42 | 1.8 % | $ 93.7 M | Nasdaq Global Select Market | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 191.6 | 0.14 % | $ 21.3 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 515.18 | -3.07 % | $ 194 B | NYSE,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.17 | 0.58 % | $ 4.07 M | Nasdaq Global Select Market | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.69 | -2.4 % | $ 61.9 M | Nasdaq Global Select Market | Irlanda |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.